Ocuphire Posts Second Phase III Success In Reversing Pupil Dilation

 
• By Joseph Haas
  
Eye exam
Ocuphire hopes Nyxol will prove a popular option with eye exam patients • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D